Multiple Sclerosis—A Demyelinating Disorder and Its Dental Considerations—A Literature Review with Own Case Report
暂无分享,去创建一个
M. Cicciu' | H. Abed | M. Al-Zahrani | K. Srivastava | Deepti Shrivastava | G. Minervini | K. A. Al Johani | Khalid Al Johani | Mashael Fudah | Deepti Shrivastava | Marco Cicciù | Giuseppe Minervini | Mashael Fudah
[1] V. Ronsivalle,et al. Prevalence of Temporomandibular Disorders in subjects affected by Parkinson Disease: a systematic review and metanalysis. , 2023, Journal of oral rehabilitation.
[2] L. Fiorillo,et al. Economic inequalities and temporomandibular disorders: a systematic review with meta-analysis. , 2023, Journal of oral rehabilitation.
[3] Sahana Shivakumar,et al. Impact of temporomandibular disorders on Oral Health Related Quality of Life: A systematic review and meta-analysis. , 2023, Journal of oral rehabilitation.
[4] L. Fiorillo,et al. Prevalence of temporomandibular disorders in children and adolescents evaluated with Diagnostic Criteria for Temporomandibular disorders (DC/TMD): A systematic review with meta-analysis. , 2023, Journal of oral rehabilitation.
[5] Neil Patel,et al. Pathogenesis and management of multiple sclerosis revisited. , 2022, Disease-a-month : DM.
[6] Foziah Alshamrani,et al. Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab , 2022, Neurology and Therapy.
[7] A. R. Castro,et al. Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations—Case Report , 2022, Diseases.
[8] R. Bunyan,et al. Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia , 2021, Multiple sclerosis international.
[9] N. Alqhtani,et al. Cortisol in Oral and Maxillofacial Surgery: A Double-Edged Sword , 2021, International journal of dentistry.
[10] C. Bryant,et al. Multiple sclerosis and its impact on dental care , 2021, British Dental Journal.
[11] Z. Khurshid,et al. Novel Approach to Dental Biofilm Management through Guided Biofilm Therapy (GBT): A Review , 2021, Microorganisms.
[12] A. Nagarajappa,et al. Evaluation of temporomandibular disorders among dental students of Saudi Arabia using Diagnostic Criteria for Temporomandibular Disorders (DC/TMD): a cross-sectional study , 2021, BMC oral health.
[13] A. Rae-Grant,et al. Diagnosis and Treatment of Multiple Sclerosis: A Review. , 2021, JAMA.
[14] J. Flores-Rivera,et al. Cyclophosphamide treatment in active multiple sclerosis , 2021, Neurological Sciences.
[15] E. Celius,et al. Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives , 2021, Patient preference and adherence.
[16] E. Leray,et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition , 2020, Multiple sclerosis.
[17] R. Bunyan,et al. Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia , 2020, Multiple sclerosis journal - experimental, translational and clinical.
[18] M. Sghaireen,et al. Microbiological and Clinical evaluation of Neem gel and Chlorhexidine gel on Dental Plaque and Gingivitis in 20-30 Years Old Adults: A Randomized Parallel-Armed, Double-Blinded Controlled Trial , 2020, Journal of pharmacy & bioallied sciences.
[19] Z. Khurshid,et al. BactericidalActivity of Crevicular Polymorphonuclear Neutrophils in Chronic Periodontitis Patients and Healthy Subjects under the Influence of Areca Nut Extract: An In Vitro Study , 2020 .
[20] H. Ford. Clinical presentation and diagnosis of multiple sclerosis. , 2020, Clinical medicine.
[21] G. Ruoppolo,et al. Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life , 2020, International journal of environmental research and public health.
[22] M. Etemadifar,et al. Incidence and prevalence of multiple sclerosis in persian gulf area: A systematic review and meta-analysis. , 2020, Multiple sclerosis and related disorders.
[23] R. Bunyan,et al. Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study , 2019, BMC Neurology.
[24] Akram Ataei,et al. Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 2. , 2019, International journal of physiology, pathophysiology and pharmacology.
[25] E. Alvarez,et al. Monoclonal Antibodies in Multiple Sclerosis: Present and Future , 2019, Biomedicines.
[26] A. Truini,et al. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options , 2019, The Journal of Headache and Pain.
[27] G. Giovannoni,et al. Multiple sclerosis – a review , 2018, European journal of neurology.
[28] M. Filippi,et al. Multiple sclerosis , 2018, Nature Reviews Disease Primers.
[29] F. Lublin,et al. Clinical Course of Multiple Sclerosis. , 2018, Cold Spring Harbor perspectives in medicine.
[30] Nikolaos A Patsopoulos,et al. Genetics of Multiple Sclerosis: An Overview and New Directions. , 2018, Cold Spring Harbor perspectives in medicine.
[31] A. White,et al. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. , 2017, Clinical therapeutics.
[32] Anders Larsson,et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet Neurology.
[33] H. Algahtani,et al. Quality of life among multiple sclerosis patients in Saudi Arabia , 2017, Neurosciences.
[34] M. Nakajima,et al. Anesthetic Management of a Patient With Multiple Sclerosis. , 2017, Anesthesia progress.
[35] G. Spagnuolo,et al. Interface Between MTA and Dental Bonding Agents: Scanning Electron Microscope Evaluation , 2017, Journal of International Society of Preventive & Community Dentistry.
[36] DrKumarChandan Srivastava,et al. JOURNEY TOWARDS THE 3D DENTAL IMAGING- THE MILESTONES IN THE ADVANCEMENT OF DENTAL IMAGING. , 2016 .
[37] S. Razavi,et al. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy , 2016, Cell journal.
[38] E. Granieri,et al. The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study , 2016, PloS one.
[39] K. Burchiel,et al. Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature , 2016, Journal of Medical Case Reports.
[40] L. Călugăru,et al. Evoked Potentials in Multiple Sclerosis Diagnosis and Management , 2016, Current health sciences journal.
[41] O. Ciccarelli,et al. MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.
[42] G-Q Zhang,et al. Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider. , 2015, European review for medical and pharmacological sciences.
[43] M. Rovaris,et al. Drug therapy for multiple sclerosis , 2014, Canadian Medical Association Journal.
[44] David H. Miller,et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging , 2014, The Lancet Neurology.
[45] Jeffrey A. Cohen,et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.
[46] A. Ascherio. Environmental factors in multiple sclerosis , 2013, Expert review of neurotherapeutics.
[47] J. Sheu,et al. Association between multiple sclerosis and chronic periodontitis: a population‐based pilot study , 2013, European journal of neurology.
[48] P. Rieckmann,et al. Multiple sclerosis in the Arabian Gulf countries: a consensus statement , 2013, Journal of Neurology.
[49] S. Danesh-Sani,et al. Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[50] Hans Lassmann,et al. Progressive multiple sclerosis: pathology and pathogenesis , 2012, Nature Reviews Neurology.
[51] D. Grover,et al. Systemic antibiotic therapy in periodontics , 2012, Dental research journal.
[52] E. Martínez-Pérez,et al. Oral health status of a population with multiple sclerosis , 2011, Medicina oral, patologia oral y cirugia bucal.
[53] Rock Heyman,et al. Multiple Sclerosis: Pathogenesis and Treatment , 2011, Current neuropharmacology.
[54] F. Ashtari,et al. Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[55] K. Stockl,et al. Improving patient self-management of multiple sclerosis through a disease therapy management program. , 2010, The American journal of managed care.
[56] K. Rammohan. Cerebrospinal fluid in multiple sclerosis , 2009, Annals of Indian Academy of Neurology.
[57] D. Ontaneda,et al. Management of acute exacerbations in multiple sclerosis , 2009, Annals of Indian Academy of Neurology.
[58] J. Epstein,et al. Multiple sclerosis: an update for oral health care providers. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[59] G. Cruccu,et al. Trigeminal neuralgia and pain related to multiple sclerosis , 2009, PAIN®.
[60] A J Thompson,et al. Multiple sclerosis: diagnosis and the management of acute relapses , 2005, Postgraduate Medical Journal.
[61] H. Weiner. Immunosuppressive treatment in multiple sclerosis , 2004, Journal of the Neurological Sciences.
[62] Polman,et al. Drug treatment of multiple sclerosis , 2000, The Western journal of medicine.
[63] D. Chemaly,et al. Oral and maxillofacial manifestations of multiple sclerosis. , 2000, Journal.
[64] H. Huggins,et al. Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal. , 1998, Alternative medicine review : a journal of clinical therapeutic.
[65] G. Seymour,et al. A preliminary study into the dental health status of multiple sclerosis patients. , 1993, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[66] M. Mumenthaler. [Multiple sclerosis, diagnosis and differential diagnosis]. , 1967, Praxis.
[67] T. Fog,et al. [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.
[68] M. Kaminska,et al. Multiple Sclerosis and related disorders. , 2022, Handbook of Clinical Neurology.
[69] M. Stasiołek,et al. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. , 2020, Multiple sclerosis and related disorders.
[70] T. Alsaadi,et al. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. , 2019, Multiple sclerosis and related disorders.
[71] T. Olsson,et al. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.